Cessation Therapeutics

"Fentanyl Is The #1 Killer Of Americans 18 To 45 We Can Save Lives​ Cessation is developing a novel antibody therapy to prevent overdose related to fentanyl and fentanyl analogs." That is how Cessation Therapeutics introduces itself. When AI engines look at it, they find little to work with. It scores 4.1 out of 10.

On its own pages the site does well on a clear heading structure and a clearly stated business identity. It is passable on a few credibility markers, basic crawler access and partial sitemap and link coverage. What holds it back is structured data describing the business.

Off the page there is only faint evidence that only a handful of sites link to it. Beyond that, the domain does not yet read as established, AI engines do not yet recognise it as a distinct business, there is no press coverage to draw on, nobody is discussing it where AI engines look and it does not come up on Reddit. None of that can be fixed on the page: it has to be earned.

AI crawlers have visited once in our tracking, including ClaudeBot (Anthropic). The site links to no social profiles, so there is nothing tying the brand to a wider presence.